Showing results (781-790 of 1,892) with videos related to

Sort By:
Pageof 190
Immunotherapy|July 7, 2022
Cost-effectiveness of pembrolizumab plus chemotherapy as first-line treatment in PD-L1-positive metastatic triple-negative breast cancerMin Huang, Peter Fasching, Amin Haiderali, et al.
Immunotherapy|January 5, 2021
Acute interstitial nephritis and PR3-ANCA following reintroduction of pembrolizumab: a case reportMatthew Mulroy, Sanaz Ghafouri, Anthony Sisk, et al.
Immunotherapy|January 5, 2021
An anti-CD6 antibody for the treatment of COVID-19 patients with cytokine-release syndrome: report of three casesLázaro Manuel Filgueira, Julio Betancourt Cervantes, Orlando Adolfo Lovelle, et al.
Immunotherapy|June 11, 2021
Efficacy of immunotherapy in KRAS-mutant non-small-cell lung cancer with comutationsAlexander P Davis, Wendy A Cooper, Michael Boyer, et al.
Immunotherapy|June 11, 2021
Immunotherapy versus standard chemotherapy for treatment of extensive-stage small-cell lung cancer: a systematic reviewXingyu Liu, Huifang Xing, Hongbing Zhang, et al.
Immunotherapy|June 18, 2021
Efficacy of immune checkpoint inhibitor therapy in patients with RET fusion-positive non-small-cell lung cancerNaleen Raj Bhandari, Lisa M Hess, Yimei Han, et al.
Immunotherapy|May 27, 2022
Barriers and solutions to improve access for chimeric antigen receptor therapiesSachin Kamal-Bahl, Justin T Puckett, Indranil Bagchi, et al.
Immunotherapy|February 2, 2021
Phase I studies of peptide vaccine cocktails derived from GPC3, WDRPUH and NEIL3 for advanced hepatocellular carcinomaMasafumi Ikeda, Takuji Okusaka, Izumi Ohno, et al.
Immunotherapy|January 21, 2021
Clinical efficacy of immune checkpoint inhibitors in patients with brain metastasesVincenzo Di Nunno, Giacomo Nuvola, Mirta Mosca, et al.
Immunotherapy|February 25, 2021
Safety and efficacy of immune checkpoint inhibitors in non-small-cell lung cancer: focus on challenging populationsLodovica Zullo, Giovanni Rossi, Chiara Dellepiane, et al.
Pageof 190